Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench

Mohga El-Abbadi1, Cecilia M Giachelli

  • 1Bioengineering Department, University of Washington, Seattle, Washington 98195, USA.

Insights

Vascular calcification, linked to mineral metabolism disturbances in chronic kidney disease patients, significantly lowers survival rates. Understanding these processes is key to developing new treatments for this condition.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Mineral Metabolism

Background:

  • Cardiovascular disease is the primary cause of death in chronic kidney disease (CKD) patients.
  • Mineral metabolism disturbances, particularly elevated calcium and phosphate, are implicated in CKD-related cardiovascular complications.
  • Vascular and valvular calcification are significant contributors to poor prognosis in CKD.

Purpose of the Study:

  • To review recent findings on the etiology of vascular calcification.
  • To emphasize pathways relevant to vascular calcification in CKD patients.
  • To highlight the link between mineral metabolism and cardiovascular risk in CKD.

Main Methods:

  • Literature review of recent studies on vascular calcification.
  • Analysis of etiological factors and regulatory pathways.
  • Focus on chronic kidney disease patient populations.

Main Results:

  • Both intimal and medial vascular calcification correlate with reduced survival in CKD patients.
  • Vascular calcification is an actively regulated process with identified inducers (calcium, phosphate, inflammatory cytokines) and inhibitors (matrix Gla protein, fetuin, pyrophosphate, osteopontin).
  • These factors contribute to the high prevalence of vascular calcification in CKD.

Conclusions:

  • Vascular calcification is a significant factor in decreased survival among CKD patients.
  • Understanding the regulatory mechanisms of vascular calcification is crucial for therapeutic development.
  • Novel therapeutics may be developed to manage or reverse vascular calcification in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...